PANADOL
NDC 0135-0539, acetaminophen, suspension, from Haleon US Holdings LLC.
- Product NDC
- 0135-0539
- Status
- Listed
- Labeler
- Haleon US Holdings LLC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M013
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0135-0539 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACETAMINOPHEN160 mg/5mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0135-0539-02 | 00135053902 | 1 BOTTLE in 1 CARTON (0135-0539-02) / 54.7 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0135-0539 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0135-0539 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0135-0539. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.